|Statement||James N. Parker and Philip M. Parker, editors|
|Contributions||Icon Group International, Inc|
|LC Classifications||RC378 .O34 2002eb|
|The Physical Object|
|Format||[electronic resource] /|
|Pagination||1 online resource (ix, 90 p.)|
|Number of Pages||90|
Opsoclonus-myoclonus syndrome (OMS) is a rare disorder that affects the nervous system. Symptoms include rapid, multi-directional eye movements (opsoclonus), quick, involuntary muscle jerks (myoclonus), uncoordinated movement (ataxia), irritability, and sleep disturbance. Bartos A. Effective high-dose clonazepam treatment in two patients with opsoclonus and myoclonus: GABAergic hypothesis. Eur Neurol ; Fernandes TD, Bazan R, Betting LE, da Rocha FC. Topiramate effect in opsoclonus-myoclonus-ataxia syndrome. Arch Neurol ; An association between neuroblastoma and opsoclonus-myoclonus syndrome (OMS) was described as early as within the first report on the transformation of malignant neuroblastoma to a benign ganglioneuroma. It was not recognized at that time nor was it appreciated in the subsequent follow-up report on the same patient in Cited by: Ofatumumab for refractory opsoclonus-myoclonus syndrome following neuroblastoma. Pediatr Blood Cancer ;E Battaglia T, De Grandis E, Mirabelli-Badenier M, Boeri L, Morcaldi G, Barabino P, et al. Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments. Eur J Paediatr Neurol ;
Opsoclonus-Myoclonus Syndrome in Patients With Locked-in Syndrome: A Therapeutic Porthole With Gabapentin Francesca Pistoia, Massimiliano Conson, Marco . Opsoclonus myoclonus syndrome (OMS), also known as opsoclonus-myoclonus-ataxia (OMA), is a rare neurological disorder of unknown cause which appears to be the result of an autoimmune process involving the nervous is an extremely rare condition, affecting as few as 1 in 10,, people per year. It affects 2 to 3% of children with neuroblastoma and has been reported to occur with Specialty: Neurology. Synonyms: Opsoclonus myoclonus syndrome, OMS, Kinsbourne syndrome, Ataxo-opso-myoclonus syndrome, OMA syndrome, Opsoclonus-myoclonus-ataxia syndrome, Dancing eye-dancing feet syndrome, Dancing eye syndrome, POMA syndrome, Paraneoplastic opsoclonus-myoclonus, Paraneoplastic opsoclonus-myoclonus-ataxia syndrome. ClinicalNeuropharmacology Vol. 19, No. 1, pp. CLippincott-Raven Publishers, Philadelphia Review TheImmunopharmacology ofthe Opsoclonus-Myoclonus Syndrome MichaelR. Pranzatelli DepartmentsofPediatrics, Neurology, andPharmacology, The George Washington.
Opsoclonus-myoclonus symptoms may sometimes occur in patients with brainstem lesions, together with palatal tremor, orofacial stereotypes, and abnormal posturing movements. 7 As a consequence of the brainstem lesion, patients with locked-in syndrome may occasionally show opsoclonus-myoclonus symptoms that further contribute to their disability Cited by: 지민 ＆ RM 경쾌한 캐럴 ‘Santa Claus Is Coming To Town’ | SBS 가요대전( SBS K-POP AWARDS) | SBS Enter. - Duration: Presleigh Voelker Opsoclonus Myoclonus syndrome. The best sleeping position for back pain, neck pain, and sciatica - Tips from a physical therapist - Duration: Tone and Tighten Recommended. Opsoclonus-myoclonus ataxia syndrome (OMS) is a rare immune mediated paraneoplastic syndrome that occurs in approximately 2 to 3% of children with neuroblastoma. Children with neuroblastoma associated opsoclonus-myoclonus tend to have a favorable prognosis from the .